Kenneth Carl Anderson
Director · C4 Therapeutics, Inc.
Individual
- 2024
- Oct 2, 2026
- 8
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kenneth Carl Anderson files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Leonard Reyno - $22K in CCCC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kenneth Carl Anderson?
Kenneth Carl Anderson is a corporate insider, tracked as Director of C4 Therapeutics, Inc. (CCCC). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Kenneth Carl Anderson submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
